Technology News About BIOMARIN PHARMACEUTICAL INC

biomarin.com

3001 employees

Since 1997

386481st at Alexa

BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. ...

Learn More about Tech Company News pages.

Articles Around the Web

Enzyme Replacement Therapy Market Latest Research On Industry Growth, Trends, Top Players, & Key Regions By 2027Published at Feb 23, 2021 by MarketWatch

The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of EarningsPublished at Feb 20, 2021 by Benzinga on MSN.com

Biomarin Pharmaceutical Inc. hosts conference call for investorsPublished at Feb 19, 2021 by Business Insider

BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of DirectorsPublished at Feb 19, 2021 by Associated Press

Hemophilia Market Sales and Revenue by Companies, Regions, Type and Application till 2027 | ARCPublished at Feb 19, 2021 by MarketWatch

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CEO Jean Jacques Bienaime Sells 8,000 SharesPublished at Feb 19, 2021 by modernreaders.com

Earnings Preview: BioMarin Pharmaceutical (BMRN) Q4 Earnings Expected to DeclinePublished at Feb 18, 2021 by Business Insider

California Public Employees Retirement System Purchases 25,688 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Published at Feb 10, 2021 by modernreaders.com

5 Undervalued Innovative StocksPublished at Feb 10, 2021 by Morningstar%2c Inc.